Finkelstein Thompson LLP Announces Investigation of NightHawk Radiology

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of NightHawk Radiology (“NightHawk or the “Company”) (NASDAQ: NHWK) concerning the proposed acquisition of the Company by Virtual Radiologic. Under the terms of the offer, NightHawk shareholders will receive $6.50 in cash for each share of the Company's common stock held in a transaction valued at approximately $170 million.

The investigation is focused on the potential unfairness of the price to NightHawk shareholders, the process by which the Board of Directors considered the transaction, and potential conflicts of interests among the Company’s Board members. In particular, although shareholders will receive $6.50 in cash per share, shares of NightHawk stock traded over $7.00 a share within the past year.

If you are interested in discussing your rights as a NightHawk shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at [phone] or by email at [e-mail].

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.